Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03772353 |
|---|---|
| Brief Title: | Pyrotinib, Dalpiciclib(SHR6390) and Endocrine Therapy in Subjects With Dual-receptor Positive(ER+/HER2+) Advanced Breast Cancer (PLEASURABLE) |
| First Submitted : | December 10, 2018 |
| First Submitted that Met QC Criteria : | December 10, 2018 |
| First Posted : | December 11, 2018 |
| Last Update Submitted that Met QC Criteria : | March 5, 2023 |
| Last Update Posted : | March 7, 2023 |